117th Congress · HOUSE RESOLUTIONBILL

H.Res. 484 — Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

“Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.”

Commerce

Introduced Jun 17, 2021

Last action Nov 1, 2022

Pipeline · Resolution

Step 1

Introduced

Jun 17, 2021

Step 2

Referred

Nov 1, 2022

Judiciary

Step 3

Committee

Step 4

House floor

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 1 sectionsIntroduced in House

Timeline · 3 actions

Nov 1, 2022

Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

Jun 17, 2021

Introduced in House

Jun 17, 2021

Referred to the House Committee on the Judiciary.